NEWS On the Health Affairs Blog: Silver Suggests Patent Buyouts and Licensing Changes As Strategy For Lowering Brand Drug Prices 4/05/17

In the latest post on the IVI-sponsored Health Affairs blog series, Jonathan Silver suggests the key to lowering brand drug prices may be found through patent buyouts and changes to licensing policy. In particular, Silver proposes that non-profit entities be created and funded to purchase and license IP rights for certain branded drugs.

Read more here.